相关临床试验
2
2 进行中
药物批准
0
批准总数
监管机构
0
监管机构数
成立时间
1973
暂无试验阶段数据
尚未招募
2
100.0%
暂无批准数据
- Yanagisawa Masashi of the University of Tsukuba shared the Lasker Basic Medical Research Award with Stanford's Emmanuel Mignot for identifying orexin and its role in narcolepsy. - Three Chugai Pharmaceutical researchers received the Clinical Medical Research Award for developing Hemlibra, an antibody treatment for hemophilia A. - The four are the first Japanese scientists in 12 years to win the awards, which the Lasker Foundation will present in New York on September 17. - Lasker Awards are widely viewed as predictors of Nobel Prizes, with past winner Shinya Yamanaka later receiving the 2012 Nobel Prize in Physiology or Medicine.
- Researchers at JAIST, Daiichi Sankyo, and University of Tsukuba developed AUN, a revolutionary bacterial cancer therapy that eliminates tumors without requiring immune cell function. - The therapy combines Proteus mirabilis and Rhodopseudomonas palustris bacteria that work synergistically to destroy tumor vasculature and cancer cells while minimizing side effects. - AUN represents a paradigm shift for immunocompromised cancer patients who cannot benefit from conventional immunotherapies, with clinical trials planned within six years.
